{"schema_version":"secwatch.filing_event.v1","accession":"0000896264-25-000178","form_type":"8-K","ticker":"USNA","cik":"0000896264","company_name":"USANA HEALTH SCIENCES INC","filed_at":"2025-07-22T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.634736+00:00","generated_at":"2026-05-18T04:51:15.524482+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"USANA Q2: net sales +11% to $236M, net earnings -7%; FY guidance reiterated","bullets":["Net sales $236M (+11% YoY); net earnings $9.7M (-7% YoY); diluted EPS $0.52 (-4% YoY).","Adjusted diluted EPS $0.74 (+36% YoY); adjusted EBITDA $30.5M (+13% YoY).","Direct selling Active Customers fell 11% YoY to 418k; Hiya subscribers 200.4k.","Repurchased 528k shares for $15M; ended quarter debt-free with $151M cash.","Reiterated FY2025 outlook: net sales $920M-$1.0B, adjusted EPS $2.35-$3.00."],"urls":{"canonical":"https://secwatch.observer/filing/0000896264-25-000178","json":"https://secwatch.observer/filing/0000896264-25-000178.json","markdown":"https://secwatch.observer/filing/0000896264-25-000178.md","text":"https://secwatch.observer/filing/0000896264-25-000178.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/896264/000089626425000178/0000896264-25-000178-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/896264/000089626425000178/usna-20250722.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T04:51:15.524482+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}